News and Inspirational Stories

By John McMahon Please help John achieve his $2,500 donation goal by donating on his fundraising page: https://events.lustgarten.org/fundraiser/4103320. Before I had even turned 40, the unthinkable happened: I lost both of my parents—my mom to pancreatic cancer, and just 10 months later, my dad to melanoma. My mom, Grace, was the center of our family […]

My parents, two older sisters and I have always been a very close-knit family—a bond that grew immeasurably stronger when my father was diagnosed with the unimaginable: pancreatic cancer. In July 2020, my dad started experiencing abdominal discomfort and was diagnosed with pancreatitis, an inflammation of the pancreas. The doctors suspected this was caused by […]

“ARE YOU READY FOR THE ROLLER COASTER?” My mom and I have matching “warrior” tattoos. Hers is on her ankle and says “warrior” and includes a purple heart. Mine contains an inspirational quote on my thigh: Faith whispers to the warrior, “You cannot withstand the storm.” The warrior whispers back, “I am the storm.” To […]

“You’ll never walk alone.” I never imagined these song lyrics—from a song featured in the musical Carousel—would have such a profound impact on my life or would be such a source of comfort during the most painful time I’ve ever experienced. In 2010, I planned a spa trip to celebrate my birthday with my three […]

Newswise — A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins. Their findings, published online Sept. 16 in Cell, could offer hope to patients with this deadly disease. […]

Pancreatic cancer is tricky to identify. In the early stages, there might not be much—if any—indication something is even wrong, and that’s exactly why doctors often refer to it as a “silent killer.” Most recently, the deadly disease took the life of actor Willie Garson. Best known for his role as Stanford Blatch on Sex […]

The incidental identification of pancreatic cysts has become more common with the increasing use of imaging modalities in clinical practice. Currently, an estimated 15% of Americans are believed to harbor a pancreatic cyst.1 Unlike other cysts within the body, pancreatic cysts are unique in that many pose an increased risk for development of pancreas cancer over […]

A test that spots pancreatic cancer from a single drop of blood could improve survival rates. The first blood test for early diagnosis of the hard-to-spot disease, it could be available within months. Pancreatic cancer has the lowest survival rate of the common cancers, with 7.3 per cent of patients alive five years after diagnosis, […]

Preliminary analysis of data from an ongoing investigator-initiated, single-center Phase 1 study supported by BioNTech and Genentech and conducted at Memorial Sloan Kettering Cancer Center, New York, United States. Autogene Cevumeran, a fully individualized mRNA cancer immunotherapy (iNeST) demonstrated that vaccine-induced immunity significantly correlates with delayed tumor recurrence in patients with resected pancreatic ductal adenocarcinoma.

Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies.

When you’re facing a pancreatic cancer diagnosis, humor may be tough to come by. Instead, feelings of grief, sadness, depression and anxiety become so all-consuming that getting a chuckle from even the most hilarious prank seems like an impossibility. But here’s the thing: It turns out that laughter — whether forced or spontaneous — is […]

Results from an ongoing phase 2b GRECO-2 clinical trial show that the novel drug GC4419 may be promising in treating patients with unresectable or borderline resectable locally advanced pancreatic cancer who are undergoing stereotactic body radiation therapy (SBRT). When given with SBRT, the drug led to statistically significant improvements over placebo plus SBRT in progression-free […]

Noxopharm Ltd (ASX:NOX) has delivered encouraging preclinical data from its novel ‘dual-cell’ therapy drug that attacks pancreatic cancer in a different and innovative way.

With a five-year survival rate of only 11%, pancreatic cancer patients need more effective therapies. A new form of immunotherapy is showing promise, as it shrank metastases and stopped progression of one patient’s advanced pancreatic cancer after other forms of treatment had failed. The results were published in the June 1 issue of the New […]

Researchers have managed to tame pancreatic cancer in a woman whose cancer was far advanced and after other forms of treatment had failed.

UTSW study identifies a subset of cancer-associated fibroblasts that offers a new target to attack deadly disease and break the shield that protects pancreatic cancer from immunotherapy.

The annual American Society of Clinical Oncology (ASCO) meeting brings together scientists from across the country who are studying every type of cancer to share the latest results from the lab and the clinic. This year’s headlines focused heavily on a small study of immunotherapy in rectal cancer that achieved 100% remission in all 14 […]

Read our “Need to Know” summary and watch “Leading the Way: Equity, Accessibility and Diversity in Pancreatic Cancer Research” in its entirety on our YouTube channel.

Pingping Hou, PhD, of Rutgers Cancer Institute of New Jersey and Edwin Manuel, PhD, of the City of Hope, were announced at the American Association for Cancer Research (AACR) Annual Meeting 2022 as the latest recipients of the Lustgarten FoundationAACR Career Development Awards for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg and John […]